Uploaded December 2023 | Updated September 2026, 2 hours ago

---

Join us at NASS 2023 in Los Angeles as Doctech.live sits down with Jordan Katz, Vice President of Research & Development at Orthobond Corporation, a game-changing antimicrobial technology company. Orthobond is poised to transform the medical device industry and beyond with its revolutionary OstaGUARD surface treatment. Discover how this breakthrough technology is set to safeguard patient care, prevent infections, and revolutionize various industries.

Chapters:
00:00 - Introduction
00:18 - About Orthobond Corporation
02:00 - FDA Approval Progress
04:08 - Company Origins
06:12 - Contamination Challenges
07:49 - Future Trade Shows

Don't miss this in-depth interview with Orthobond Corporation, a company poised to change the game in healthcare and beyond. Subscribe to Doctech.live for more cutting-edge coverage of health and medicine innovations.

To learn more about OrthoBond - orthobond.com
To learn more about DocTech.LIVE - https://doctech.live/
To learn more about Ghost Productions Inc. - ghostproductions.com